» Articles » PMID: 32881892

Low-frequency Variation Near Common Germline Susceptibility Loci Are Associated with Risk of Ewing Sarcoma

Abstract

Background: Ewing sarcoma (EwS) is a rare, aggressive solid tumor of childhood, adolescence and young adulthood associated with pathognomonic EWSR1-ETS fusion oncoproteins altering transcriptional regulation. Genome-wide association studies (GWAS) have identified 6 common germline susceptibility loci but have not investigated low-frequency inherited variants with minor allele frequencies below 5% due to limited genotyped cases of this rare tumor.

Methods: We investigated the contribution of rare and low-frequency variation to EwS susceptibility in the largest EwS genome-wide association study to date (733 EwS cases and 1,346 unaffected controls of European ancestry).

Results: We identified two low-frequency variants, rs112837127 and rs2296730, on chromosome 20 that were associated with EwS risk (OR = 0.186 and 2.038, respectively; P-value < 5×10-8) and located near previously reported common susceptibility loci. After adjusting for the most associated common variant at the locus, only rs112837127 remained a statistically significant independent signal (OR = 0.200, P-value = 5.84×10-8).

Conclusions: These findings suggest rare variation residing on common haplotypes are important contributors to EwS risk.

Impact: Motivate future targeted sequencing studies for a comprehensive evaluation of low-frequency and rare variation around common EwS susceptibility loci.

Citing Articles

Re-envisioning genetic predisposition to childhood and adolescent cancers.

Kratz C Nat Rev Cancer. 2024; 25(2):109-128.

PMID: 39627375 DOI: 10.1038/s41568-024-00775-7.


Identification of germline cancer predisposition variants in pediatric sarcoma patients from somatic tumor testing.

Alba-Pavon P, Alana L, Gutierrez-Jimeno M, Garcia-Obregon S, Imizcoz T, Panizo E Sci Rep. 2023; 13(1):2959.

PMID: 36805510 PMC: 9941115. DOI: 10.1038/s41598-023-29982-2.


Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding.

Lee O, Rodrigues C, Lin S, Luo W, Jones K, Brown D Am J Hum Genet. 2023; 110(3):427-441.

PMID: 36787739 PMC: 10027473. DOI: 10.1016/j.ajhg.2023.01.017.


Small round cell sarcomas.

Cidre-Aranaz F, Watson S, Amatruda J, Nakamura T, Delattre O, de Alava E Nat Rev Dis Primers. 2022; 8(1):66.

PMID: 36202860 DOI: 10.1038/s41572-022-00393-3.


An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.

Shulman D, Whittle S, Surdez D, Bailey K, de Alava E, Yustein J NPJ Precis Oncol. 2022; 6(1):65.

PMID: 36115869 PMC: 9482616. DOI: 10.1038/s41698-022-00307-2.


References
1.
Lawrence M, Stojanov P, Polak P, Kryukov G, Cibulskis K, Sivachenko A . Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013; 499(7457):214-218. PMC: 3919509. DOI: 10.1038/nature12213. View

2.
Jawad M, Cheung M, Min E, Schneiderbauer M, Koniaris L, Scully S . Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome: an analysis of 1631 cases from the SEER database, 1973-2005. Cancer. 2009; 115(15):3526-36. DOI: 10.1002/cncr.24388. View

3.
Pedersen E, Menon R, Bailey K, Thomas D, Van Noord R, Tran J . Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States. Cancer Res. 2016; 76(17):5040-53. PMC: 5010452. DOI: 10.1158/0008-5472.CAN-15-3422. View

4.
Gangwal K, Sankar S, Hollenhorst P, Kinsey M, Haroldsen S, Shah A . Microsatellites as EWS/FLI response elements in Ewing's sarcoma. Proc Natl Acad Sci U S A. 2008; 105(29):10149-54. PMC: 2481306. DOI: 10.1073/pnas.0801073105. View

5.
Tirode F, Laud-Duval K, Prieur A, Delorme B, Charbord P, Delattre O . Mesenchymal stem cell features of Ewing tumors. Cancer Cell. 2007; 11(5):421-9. DOI: 10.1016/j.ccr.2007.02.027. View